4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000031
Chief Financial Officer sold 2,814 shares at $20.86 ($58,700)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barnett Eva Renee Chief Financial Officer | 2025-02-19 | Sale | −2,814 | $20.86 | $58,700 | 321,952 | D |
| Open-market sales · 2,814 sh · avg $20.86 · $58,700 | |||||||
Loading xslF345X05/wk-form4_1740171904.xml…